McAndrews

About

  • The Orange Book blog team are a group of attorneys with McAndrews, Held and Malloy, which is a full-service IP firm representing both brands and generics in various aspects of IP law. This blog does not provide legal advice. If you are seeking legal advice, please contact the author directly.

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is not edited by McAndrews, Held & Malloy, Ltd. ("MHM") or its clients. The views expressed are solely those of the authors, and may not reflect the views of MHM or its clients. No part of Orange Book Blog--whether information, commentary, or other--may be attributed to MHM or its clients. MHM represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MHM clients. Orange Book Blog will always strive to be unbiased. All information on Orange Book Blog should be double-checked for its accuracy and current applicability.

« Federal Circuit Vacates Dismissal of Delaratory Judgment Counterclaims in Fosamax Case as Moot | Main | OBB News Briefs »

July 18, 2008

C5 "Biotech Patenting" Conference, London, September 23-24

C5 will be bringing its popular "Biotech Patenting" conference to London on September 23-24.

According to C5, the conference "provides updates on the latest developments in biotech patenting, including recent case law and regulatory developments."  The conference is unique in offering an international perspective on biotechnology patent law:  experts from Europe, Asia and the United States will be speaking.  One of the highlights will be a keynote address by Judge Randall Rader of the U.S. Court of Appeals for the Federal Circuit.

The agenda includes numerous talks and panel discussions that should be of interest to Orange Book Blog readers, such as:

  • "Critical Update on Legislative and Policy Developments at the UK-IPO and EPO," presented by officials from the UK-IPO and the EPO
  • "Review of Recent EPO and EU National Court Biotech Decisions"
  • "Impact of the EPC 2000 on Medical Use Claims"
  • "Analysis of the Latest Decisions of the U.S. Courts and Their Implications"
  • "Obviousness Determinations After KSR v. Teleflex"
  • "How to Successfully Obtain and Enforce Your Biotech Patents in China and India"
  • "Comparison of the U.S. and European Legal Issues Surrounding Biosimilars:  Legislation, Case Law and Approvals to Date"
  • "Managing Your Biotech Patent Litigation: In-House and Outside Counsel Perspectives"

In addition, two pre-conference workshops are offered on September 22:  "How to Conduct Effective IP Due Diligence" and "Successfully Evaluating Freedom to Operate."

Orange Book Blog readers can receive a 10% discount off the registration fee with the following code:  789L09.OBB.

For more information or to register, please visit the conference website.

Posted by in Conferences |

Comments

The comments to this entry are closed.